Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant IgA protease of bacterium Heamophilus influenzae |
|---|---|
| Date Designated: | 04/18/2011 |
| Orphan Designation: | Treatment of immunoglobulin A nephropathy (IgAN, Berger's disease). |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Shire Human Genetics Therapies 300 Shire Way Lexington, Massachusetts 02421 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







